URGN Competitors & Alternatives
Compare UroGen Pharma Ltd with similar stocks in the same industry
Biotechnology
URGN
Main Stock$34.88
Tradestie Score
68
Market Cap
$824.20M
Revenue Growth
2.0%
Analyst Upside
+72.0%
Top Competitors
218 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
LQDA
Liquidia Corporation Common Stock
|
$40.64
|
$1.90B | 26.3 | 52 | Compare |
|
VERA
Vera Therapeutics, Inc. Class A Common Stock
|
$29.05
|
$1.84B | - | 65 | Compare |
|
IMCR
Immunocore Holdings plc American Depositary Shares
|
$31.37
|
$1.81B | - | 42 | Compare |
|
ABCL
AbCellera Biologics Inc. Common Shares
|
$11.63
|
$1.78B | - | 66 | Compare |
|
DYN
Dyne Therapeutics, Inc. Common Stock
|
$15.46
|
$1.78B | - | 57 | Compare |
|
TWST
Twist Bioscience Corporation Common Stock
|
$138.96
|
$1.77B | - | 58 | Compare |
|
VRDN
Viridian Therapeutics, Inc. Common Stock
|
$22.28
|
$1.74B | - | 45 | Compare |
|
CLDX
Celldex Therapeutics, Inc
|
$28.89
|
$1.68B | - | 64 | Compare |
|
MNKD
Mannkind Corporation
|
$3.15
|
$1.65B | - | 51 | Compare |
|
EWTX
Edgewise Therapeutics, Inc. Common Stock
|
$39.29
|
$1.63B | - | 58 | Compare |
More URGN Analysis
Data updated: Oct 23, 2026 | Industry: Biotechnology (SIC 2834)
218 stocks in this industry